News

For humans, it's easy to envision an object with different attributes. But computers still struggle with imagination. A research team has now developed an AI that uses human-like capabilities to imagine a never-before-seen object with different attributes.

Researchers have isolated a panel of human monoclonal antibodies from subjects with a history of acute gastroenteritis that neutralize a broad range of norovirus variants in laboratory tests.

Research has shown that the Neuraminidase 3 (Neu3) enzyme is responsible for the onset and progression of colitis, a chronic digestive disease caused by inflammation of the colon.

In a new retrospective observational study, researchers from Tel Aviv and the US matched 15,060 pregnant women in Israel into vaccinated/unvaccinated pairs to determine the efficacy of the Pfizer COVID-19 vaccine. Their results show that vaccination with BNT162b2 in pregnant women significantly lowered the risk of SARS-CoV-2 infection, with an efficacy rate of 78%.

Research indicates that losartan, a blood pressure drug, may benefit patients with neurofibromatosis type 2, a hereditary condition associated with noncancerous tumors along the nerves in the brain that are involved with hearing and balance.

Statins are commonly used to reduce blood cholesterol levels by blocking liver enzymes responsible for making cholesterol. Research has confirmed that patients taking statin medications had a 41% lower risk of in-hospital death from COVID-19.

Western University's Kibret Mequanint and collaborators have found a novel use for snake venom. They have designed a body tissue "super glue" that can stop life-threatening bleeding in seconds.

Scientists have waited months for access to high-accuracy protein structure prediction since DeepMind presented remarkable progress in this area at the 2020 Critical Assessment of Structure Prediction, or CASP14, conference. The wait is now over.

A study has characterized the antibody response induced by five Ebola vaccines and has identified features and functions that could serve as vaccine correlates of protection.

Uveal melanoma (UM) is a rare eye cancer, and the high mortality rate has remained unimproved for 40 years. A small molecule inhibitor, KCN1, has been identified in a preclinical study. In mouse models, the inhibitor strongly limited primary disease in the eye and metastatic tumor dissemination to the liver.